Work

Sunitinib malate (SU) plus interferon (IFN) in first line metastatic renal cell cancer (mRCC): Results of a dose-finding study

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.5101

Authors: G. V. Kondagunta, G. R. Hudes, R. Figlin, G. Wilding, S. Hariharan, S. N. Kempin, R. Fayyad, S. Hoosen, R. J. Motzer

Institutions: Fox Chase Cancer Center, City Of Hope National Medical Center, Memorial Sloan Kettering Cancer Center, Pfizer (United States)

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3009366418

Cites:

Cited by: 12

Related to: 10